New Products

ISELIN, N.J. — The makers of LifeStyles condoms today announced the release of the new Turbo condom. The Turbo condom is lubricated inside and out with LifeStyles' proprietary Excite gel.

HYDERABAD, India — Dr. Reddy's has launched a drug for treating acne, the company said Friday.

The Indian generic drug maker announced the launch of Zenatane (isotretinoin) capsules in the 20-mg and 40-mg strengths. The drug is a therapeutically equivalent generic version of Roche's Accutane. The Food and Drug Administration also approved the drug in the 10-mg strength.

Various versions of the drug had sales of about $309 million during the 12-month period that ended in January, according to IMS Health.

BENTONVILLE, Ark. — As Reuters reported yesterday, Walmart is considering a new delivery system that would have in-store customers deliver packages to online buyers. The delivering customers would receive a discount off their shopping bills.

NEW YORK — Looking to jazz up the shave market, Milton Moore, a Houston-based dermatologist and founder of Moore Unique Skin Care, has expanded his product portfolio with the new Silky Hydroglide Shave Gel and Post Shave Rejuvenation for Women.

Moore’s latest venture is a product that promises to provide the following user benefits:

• Lubricates, moisturizes and treats dry and irritated skin for the closest nick-free shave possible;

• Dermatologist developed and designed specifically for women;

PHOENIX — Vitamin Squeeze announced today the release of a full line of powdered water enhancers available in supermarkets nationwide.

Vitamin Squeeze Powder Water Enhancers come in eight flavors and three varieties:

• Multi-Vitamin (Fruit Punch, Acai Grape Pomegranate, Strawberry Watermelon and Lemonade);

• Energy (Black Cherry, Blood Orange and Blueberry Pomegranate Acai); and

WASHINGTON — A new Medicare Chronic Conditions Dashboard announced today by Marilyn Tavenner, acting administrator of the Centers for Medicare and Medicaid Services (CMS), furthers the Patient Protection and Affordable Care Act’s goals for health promotion and the prevention and management of multiple chronic conditions.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

The FDA announced the approval of J&J subsidiary Janssen Pharmaceuticals' Invokana (canagliflozin) tablets, designed for use with diet and exercise to improve blood-sugar control in adults with the disease.

NEW YORK — The Department of Health and Human Services issued a new rule that it said was necessary to protect the security of health information stored online.

As required by the Health Information Technology for Economic and Clinical Health Act, which was part of the 2009 economic stimulus bill, HHS said it would change patient privacy rules in the Health Insurance Portability and Accountability Act in order to provide for privacy and security protection for information stored in electronic health records.